0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Powered by :
A new blood test can predict how ovarian cancer patients will respond to Chemotherapy. A study from the University of Cambridge, released on December 20, found that monitoring a specific cancer gene could help researchers assess how well patients responded to drug treatments.
Share this article
If you liked this article share it with your friends.they will thank you later
/shethepeople/media/agency_attachments/iUYfaBbcMozaYLoGnoov.png)
/shethepeople/media/post_banners/RhToZdjeoUQe5ou3ONVC.jpg)
2 Min read